Filter Results:
(312)
Show Results For
- All HBS Web
(312)
- People (1)
- News (58)
- Research (211)
- Events (1)
- Multimedia (1)
- Faculty Publications (97)
Show Results For
- All HBS Web
(312)
- People (1)
- News (58)
- Research (211)
- Events (1)
- Multimedia (1)
- Faculty Publications (97)
- 24 Apr 2014
- News
Giving hope and inspiration to cancer patients around the globe
Every new day is a good day for Kathryn E. Giusti (MBA 1985) since that morning in 1996 when her oncologist told her to get her affairs in order because she had a rare blood cancer, with three years to live. Leveraging her past experience as a View Details
- 01 Mar 2007
- News
In Brief
Q&A with Daniel Vasella. Initially regarded by critics as too inexperienced to lead a major pharmaceutical company, Daniel Vasella (PMD 57, 1989) has set a new standard for innovation as CEO of Novartis. The Winning Season. Last year, St.... View Details
Steve Cagnetta
Steve Cagnetta is a co-founder and Principal of Company Counsel, LLC, an out-sourced general counsel firm focused on representing emerging companies. He has spent the past 20+ years advising entrepreneurs and startups on the business and... View Details
- 25 Jun 2020
- News
Covering All Corners
Riad Armanious (MBA 2008) regards the pandemic as the greatest professional challenge he has faced as managing director of family-owned Eva Group and CEO of Eva Pharma, a multinational pharmaceutical company headquartered in Egypt. The... View Details
- 01 Dec 2003
- News
Alumni Luminaries Discuss Careers, Values with HBS Students
Internal Revenue Service. Senior advisor, The Carlyle Group. He upgraded technology and information systems and stressed customer service in a dramatic turnaround of the IRS. Daniel L. Vasella, M.D. (PMD 57, 1989), chairman and CEO of Novartis AG, the world’s... View Details
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
delivered, the way we use technology, the way pharmaceuticals are developed, the way we educate medical professionals, and who performs what kinds of services. These things are all connected, and changing one piece, or plugging an... View Details
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
leaders remain oblivious to an emerging threat or problem—a lack of attention that can plague even the most skilled executives. After European Commission regulators refused to approve General Electric's $42 billion acquisition of... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- 01 Sep 2011
- News
MBA 101: HBS Commencements Pass the Century Mark
A Time To Celebrate: As with every year, Class Day and Commencement were filled with many memorable moments. Among the general scenes of pomp and pageantry were (middle) the faculty recipients of the Class of 2011’s awards for excellence... View Details
- 15 Apr 2014
- News
Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize
Dean Nitin Nohria has announced that the Bertarelli Foundation of Switzerland, cochaired by Ernesto Bertarelli (MBA 1993), has established the Bertarelli Foundation Health & Life Sciences Entrepreneurship Fund with a generous gift to... View Details
- 15 Dec 2024
- News
After Ozempic
Back before Ozempic, when Kate Mulroney (MBA 1984) spoke at technical conferences about her work at Novo Nordisk, people often assumed she was talking about Novartis. “I’d have to explain that’s a Swiss company; we’re Danish,” says Mulroney, now head of advanced... View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
general purpose (e.g., quality management) to highly market specific (e.g., knowing how to manufacture an airplane wing). To illustrate the potential of the framework to shed new light on traditional strategy questions, the article... View Details
Keywords: Sean Silverthorne
- 01 Mar 2005
- News
Facing Ambiguity
successfully executed in a paper case.” The case, which will be taught this spring in the MBA second-year course General Management: Processes and Action, debuted last fall in a customized Executive Education program for a group of View Details
- 13 Feb 2006
- Research & Ideas
The Hidden Market for Babies
infertility: eggs, sperm, and wombs. Sometimes, these components are sold along with IVF treatment—when a couple purchases eggs, for example, they are subsequently used for an IVF procedure—but they are often provided by individual brokers. Then there are the View Details
- 23 Jun 2003
- Research & Ideas
Historically Speaking: A Roundtable at HBS
States, Europe, and Japan, it was supposed to examine two sectors: first, the chemical and pharmaceutical industries, which helped bring about the Second Industrial Revolution between the 1880s and 1920s, and second, consumer electronics... View Details
Keywords: by Jim Aisner
- 06 Feb 2007
- First Look
First Look: February 6, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=806092 Endo Pharmaceuticals (A): From LBO to...? Harvard Business School Case 806-064 Endo Pharmaceuticals was formed in 1997 as a leveraged... View Details
Keywords: Martha Lagace
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
engineers to tweak preexisting medical instruments or develop entirely new medical devices. The general deep brain stimulation procedure is now established practice: For over a decade, neurosurgeons have placed electrodes in the brains of... View Details
Keywords: Janelle Nanos
- 15 Sep 2009
- First Look
First Look: September 15
generation moving up the corporate ranks. Stimulate Creativity by Fueling Passion Authors:Teresa Amabile and Colin M. Fisher Publication:In The Blackwell Handbook of Principles of Organizational Behavior. 2nd ed. London: Wiley-Blackwell,... View Details
Keywords: Martha Lagace
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
the business world has an important leadership role to play in terms of closing the gap in health and other vital social issues," he says. When Ray Gilmartin joined Merck in June 1994 as president and CEO (he became chairman several months later), it was the first time... View Details
- 11 May 2020
- Op-Ed
Immigration Policies Threaten American Competitiveness
It is no secret that immigration has reshaped American innovation. Immigrants are the backbone of America’s most innovative industries, provide a quarter of our patent applications, and are numerous among our science and engineering superstars. Taken from World... View Details
Keywords: by William R. Kerr
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
approach not just to insurance and reimbursement, but also to the places where medical services are delivered, the way we use technology, the way pharmaceuticals are developed, the way we educate medical professionals, and who performs... View Details